{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:50:21Z","timestamp":1790286621743,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Austrian Science Fund","award":["F4704-B20"],"award-info":[{"award-number":["F4704-B20"]}]},{"DOI":"10.13039\/501100003494","name":"Herzfelder\u00b4sche Familienstiftung","doi-asserted-by":"crossref","award":["P30627-B25"],"award-info":[{"award-number":["P30627-B25"]}],"id":[{"id":"10.13039\/501100003494","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.semcancer.2019.07.025","type":"journal-article","created":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T14:50:13Z","timestamp":1565448613000},"page":"191-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms"],"prefix":"10.1016","volume":"60","author":[{"given":"Peter","family":"Valent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Sadovnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Eisenwort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wicklein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4260","key":"10.1016\/j.semcancer.2019.07.025_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","article-title":"The multistep nature of cancer","volume":"9","author":"Vogelstein","year":"1993","journal-title":"Trends Genet."},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0962-8924(99)01661-X","article-title":"Genetic instability and darwinian selection in tumours","volume":"9","author":"Cahill","year":"1999","journal-title":"Trends Cell Biol."},{"issue":"7381","key":"10.1016\/j.semcancer.2019.07.025_bib0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-genet-120213-092314","article-title":"Cancer: evolution within a lifetime","volume":"48","author":"Gerlinger","year":"2014","journal-title":"Annu. Rev. Genet."},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026542","article-title":"Evolution of premalignant disease","volume":"7","author":"Curtius","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"11","key":"10.1016\/j.semcancer.2019.07.025_bib0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrc3368","article-title":"Cancer stem cell definitions and terminology: the devil is in the details","volume":"12","author":"Valent","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4615-1463-3_11","article-title":"Evolution of secondary hematologic disorders: preMDS--&MDS--&sAML","volume":"108","author":"Preisler","year":"2001","journal-title":"Cancer Treat. Res."},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","article-title":"Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias","volume":"70","author":"Abdel-Wahab","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"10.1016\/j.semcancer.2019.07.025_bib0060","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.semcancer.2019.07.025_bib0065","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ebiom.2017.11.024","article-title":"Proposed terminology and classification of pre-malignant neoplastic conditions: a consensus proposal","volume":"26","author":"Valent","year":"2017","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0080","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.3390\/ijms20030789","article-title":"Clonal hematopoiesis with oncogenic potential (CHOP): separation from CHIP and roads to AML","volume":"20","author":"Valent","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_239083","article-title":"CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice","volume":"39","author":"DeZern","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.acr.2018.12.003","article-title":"Clonal hematopoiesis: pre-cancer PLUS","volume":"141","author":"Silver","year":"2019","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0095","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/0008-5472.CAN-12-3678","article-title":"Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implications","volume":"73","author":"Valent","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5966\/sctm.2012-0109","article-title":"Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells","volume":"2","author":"Pandolfi","year":"2013","journal-title":"Stem Cells Transl. Med."},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.exphem.2015.08.012","article-title":"Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia","volume":"43","author":"Sykes","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fonc.2017.00263","article-title":"Preleukemic hematopoietic stem cells in human acute myeloid leukemia","volume":"7","author":"Corces","year":"2017","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0115","first-page":"159","article-title":"Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology","volume":"3","author":"Valent","year":"2013","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast Cells, Mastocytosis, and Related Disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","article-title":"Advances in the classification and treatment of mastocytosis: current status and outlook toward the future","volume":"77","author":"Valent","year":"2017","journal-title":"Cancer Res."},{"issue":"11\u201312","key":"10.1016\/j.semcancer.2019.07.025_bib0130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0145-2126(96)00054-9","article-title":"Extramedullary blast crisis in chronic myeloid leukemia","volume":"20","author":"Specchia","year":"1996","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0135","first-page":"265","article-title":"Granulocytic sarcoma: a systematic review","volume":"3","author":"Yilmaz","year":"2013","journal-title":"Am. J. Blood Res."},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0140","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1200\/JCO.2012.41.9549","article-title":"Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature","volume":"31","author":"Georgin-Lavialle","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0150","doi-asserted-by":"crossref","first-page":"793","DOI":"10.12659\/AJCR.899621","article-title":"Bilineal extramedullary blast crisis as an initial presentation of chronic myeloid leukemia: a case report and literature review","volume":"17","author":"Gao","year":"2016","journal-title":"Am. J. Case Rep."},{"issue":"6464","key":"10.1016\/j.semcancer.2019.07.025_bib0155","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0160","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni1080","article-title":"Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity","volume":"5","author":"Hope","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.leu.2403649","article-title":"Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease","volume":"19","author":"Eisterer","year":"2005","journal-title":"Leukemia"},{"issue":"17","key":"10.1016\/j.semcancer.2019.07.025_bib0175","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2008.17.5745","article-title":"Chronic myeloid leukemia stem cells","volume":"26","author":"Kavalerchik","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0180","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ccr.2014.03.036","article-title":"Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo","volume":"25","author":"Woll","year":"2014","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0185","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1038\/leu.2017.172","article-title":"Preclinical modeling of myelodysplastic syndromes","volume":"31","author":"Rouault-Pierre","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2017-01-763219","article-title":"Robust patient-derived xenografts of MDS\/MPN overlap syndromes capture the unique characteristics of CMML and JMML","volume":"130","author":"Yoshimi","year":"2017","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.semcancer.2019.07.025_bib0195","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/bloodadvances.2017004903","article-title":"Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines","volume":"1","author":"Zhang","year":"2017","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0200","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41467-018-08166-x","article-title":"A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies","volume":"10","author":"Song","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-019-0460-6","article-title":"Identification of a leukemia-initiating stem cell in human mast cell leukemia","author":"Eisenwort","year":"2019","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0210","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V88.6.2162.bloodjournal8862162","article-title":"Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia","volume":"88","author":"Petzer","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.21915","article-title":"Characterization of chronic myeloid leukemia stem cells","volume":"86","author":"Gerber","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0220","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0225","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","article-title":"Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells","volume":"112","author":"Taussig","year":"2008","journal-title":"Blood"},{"issue":"37","key":"10.1016\/j.semcancer.2019.07.025_bib0230","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","article-title":"Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein","volume":"107","author":"J\u00e4r\u00e5s","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"25","key":"10.1016\/j.semcancer.2019.07.025_bib0235","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semcancer.2019.07.025_bib0240","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1158\/1078-0432.CCR-15-0767","article-title":"Identification of CD25 as STAT5-Dependent growth regulator of leukemic stem cells in ph+ CML","volume":"22","author":"Sadovnik","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0245","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/oncotarget.990","article-title":"Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations","volume":"4","author":"Gerber","year":"2013","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.semcancer.2019.07.025_bib0250","doi-asserted-by":"crossref","first-page":"33016","DOI":"10.18632\/oncotarget.9108","article-title":"Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects","volume":"7","author":"Culen","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0255","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/leu.2011.347","article-title":"Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib","volume":"26","author":"Janssen","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10428190500272507","article-title":"Detection of molecular targets on the surface of CD34+\/CD38-- stem cells in various myeloid malignancies","volume":"47","author":"Florian","year":"2006","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3324\/haematol.2010.035006","article-title":"CD34(+)\/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab\/ozogamicin","volume":"97","author":"Herrmann","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2362.2007.01746.x","article-title":"Expression of the target receptor CD33 in CD34+\/CD38-\/CD123+ AML stem cells","volume":"37","author":"Hauswirth","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0280","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2007-03-083048","article-title":"The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells","volume":"110","author":"van Rhenen","year":"2007","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.semcancer.2019.07.025_bib0285","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0290","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2018.08.014","article-title":"Prospective isolation and characterization of genetically and functionally distinct AML subclones","volume":"34","author":"de Boer","year":"2018","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0295","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.leu.2401830","article-title":"Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells","volume":"14","author":"Bendall","year":"2000","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0300","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12185-016-1961-y","article-title":"Antigen expression on a putative leukemic stem cell population and AML blast","volume":"103","author":"Garg","year":"2016","journal-title":"Int. J. Hematol"},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0305","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1182\/blood.V91.12.4523","article-title":"The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1","volume":"91","author":"M\u00f6hle","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0310","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2008.364","article-title":"The stem cell factor-c-KIT pathway must be inhibited to enable apoptosis induced by BCR-ABL inhibitors in chronic\u202f myelogenous leukemia cells","volume":"23","author":"Belloc","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/stemcells.20-3-259","article-title":"Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1","volume":"20","author":"Peled","year":"2002","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0320","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/scd.2010.0263","article-title":"Stromal-derived factor-1\/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow","volume":"20","author":"Sharma","year":"2011","journal-title":"Stem Cells Dev."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0325","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1634\/stemcells.22-2-188","article-title":"Engraftment of acute myeloid leukemia in NOD\/SCID mice is independent of CXCR4 and predicts poor patient survival","volume":"22","author":"Monaco","year":"2004","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.semcancer.2019.07.025_bib0330","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/0008-5472.CAN-03-3693","article-title":"CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD\/SCID mice","volume":"64","author":"Tavor","year":"2004","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0335","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","article-title":"CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells","volume":"7","author":"Jin","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/mp.52.4.189","article-title":"CD44 cell adhesion molecules","volume":"52","author":"Goodison","year":"1999","journal-title":"Mol Pathol"},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0345","first-page":"359","article-title":"G. Jiang. CD44 and hematologic malignancies","volume":"3","author":"Liu","year":"2006","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0350","doi-asserted-by":"crossref","first-page":"e1826","DOI":"10.1371\/journal.pone.0001826","article-title":"CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration","volume":"3","author":"Zen","year":"2008","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0355","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0360","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells","volume":"12","author":"Krause","year":"2006","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0365","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.4049\/jimmunol.1301543","article-title":"Cooperativity of CD44 and CD49d in leukemia cell homing, migration, and survival offers a means for therapeutic attack","volume":"191","author":"Singh","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0370","first-page":"235","article-title":"CD44, hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells","volume":"6","author":"Z\u00f6ller","year":"2015","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.semcancer.2019.07.025_bib0375","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1182\/blood-2018-02-833582","article-title":"CD44 is a RAS\/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis","volume":"132","author":"Mueller","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01703110","article-title":"Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia","volume":"65","author":"Reuss-Borst","year":"1992","journal-title":"Ann. Hematol."},{"issue":"1-2","key":"10.1016\/j.semcancer.2019.07.025_bib0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10428199409049647","article-title":"Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic","volume":"14","author":"Liesveld","year":"1994","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0390","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.leu.2400653","article-title":"Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation","volume":"11","author":"Lundell","year":"1997","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0395","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1999.tb01767.x","article-title":"Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts","volume":"63","author":"De Waele","year":"1999","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0400","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2141.1996.5081049.x","article-title":"Decreased L-selectin expression in\u202f CD34-positive cells from patients with chronic myelocytic leukaemia","volume":"93","author":"Kawaishi","year":"1996","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.025_bib0405","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0301-472X(02)00883-4","article-title":"Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells","volume":"30","author":"Lapidot","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0410","series-title":"Egress and Mobilization of Hematopoietic Stem and Progenitor Cells: a Dynamic Multi-facet Process","author":"Lapid","year":"2012"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0415","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/978-1-4614-2098-9_11","article-title":"Mobilization and homing of hematopoietic stem cells","volume":"741","author":"Su\u00e1rez-\u00c1lvarez","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0420","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41375-018-0087-z","article-title":"Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow micro-environment-the involvement of extracellular nucleotides and purinergic signaling","volume":"32","author":"Ratajczak","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0425","article-title":"Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche","author":"de Kruijf","year":"2019","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0430","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/blood-2003-04-1115","article-title":"Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta\/CXCL2 and GRObetaT\/CXCL2delta4","volume":"103","author":"Pelus","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0435","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood-2003-05-1589","article-title":"Characterization of hematopoietic progenitor mobilization in protease-deficient mice","volume":"104","author":"Levesque","year":"2004","journal-title":"Blood"},{"issue":"5686","key":"10.1016\/j.semcancer.2019.07.025_bib0440","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1097071","article-title":"Modulation of hematopoietic stem cell homing and engraftment by CD26","volume":"305","author":"Christopherson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1392.013","article-title":"AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1\/CXCL12-CXCR4 axis","volume":"1106","author":"Broxmeyer","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0450","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1182\/blood-2002-12-3893","article-title":"Cell surface peptidase CD26\/DPPIV mediates G-CSF mobilization of mouse progenitor cells","volume":"101","author":"Christopherson","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0455","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1634\/stemcells.2004-0342","article-title":"Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis","volume":"23","author":"Kucia","year":"2005","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0460","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2141.1996.5081049.x","article-title":"Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukaemia","volume":"93","author":"Kawaishi","year":"1996","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0465","first-page":"139","article-title":"L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression","volume":"85","author":"Mart\u00edn-Henao","year":"2000","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0470","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.leu.2403551","article-title":"CD34+ marrow progenitors from MDS patients with high levels of intramedullary apoptosis have reduced expression of alpha4beta1 and alpha5beta1 integrins","volume":"19","author":"Delforge","year":"2005","journal-title":"Leukemia"},{"issue":"3-4","key":"10.1016\/j.semcancer.2019.07.025_bib0475","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10428199209067601","article-title":"All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia","volume":"21","author":"Di Noto","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0480","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1038\/oncsis.2015.6","article-title":"RUNX1\/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1","volume":"4","author":"Ponnusamy","year":"2015","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0485","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.leu.2403626","article-title":"BCR\/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR\/ABL-positive cells","volume":"19","author":"Jongen-Lavrencic","year":"2005","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0490","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","article-title":"Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia","volume":"30","author":"Escribano","year":"1997","journal-title":"Cytometry"},{"issue":"13","key":"10.1016\/j.semcancer.2019.07.025_bib0495","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood.V98.13.3784","article-title":"Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells","volume":"98","author":"Schernthaner","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0500","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/eci.12368","article-title":"PPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia","volume":"44","author":"Valent","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0505","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","article-title":"Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML","volume":"22","author":"Duarte","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0510","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","article-title":"Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia","volume":"32","author":"Passaro","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0515","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13000","article-title":"The underestimated role of basophils in Ph+ chronic myeloid leukaemia","volume":"48","author":"Valent","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0520","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0525","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood.V99.6.2265","article-title":"Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia","volume":"99","author":"Verstovsek","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0530","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0535","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1593\/neo.12724","article-title":"Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression","volume":"14","author":"Cerny-Reiterer","year":"2012","journal-title":"Neoplasia"},{"issue":"1-2","key":"10.1016\/j.semcancer.2019.07.025_bib0540","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10428199409049647","article-title":"Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints\u202f for cellular traffic","volume":"14","author":"Liesveld","year":"1994","journal-title":"Leuk. Lymphoma"},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.025_bib0545","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1089\/scd.2011.0565","article-title":"Stromal-derived factor-1 and its receptor, CXCR4, are constitutively expressed by mouse liver sinusoidal endothelial cells: implications for the regulation of hematopoietic cell migration to the liver during extramedullary hematopoiesis","volume":"21","author":"Mendt","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0550","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1537-2995.2005.00172.x","article-title":"The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells","volume":"45","author":"Carstanjen","year":"2005","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0555","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI24751","article-title":"A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature","volume":"116","author":"Jin","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0560","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.224204","article-title":"Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells","volume":"131","author":"Buffone","year":"2018","journal-title":"J. Cell. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0565","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0570","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1054-3589(08)60431-7","article-title":"Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites","volume":"25","author":"Kishimoto","year":"1994","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0575","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1710-1492-5-13","article-title":"Stem cells, inflammation and allergy","volume":"5","author":"Blanchet","year":"2009","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0580","first-page":"5","article-title":"New insights into \"the riddle of the mast cells\": microenvironmental regulation of mast cell development and phenotypic heterogeneity","volume":"62","author":"Galli","year":"1990","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0585","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0167-5699(94)90153-8","article-title":"The riddle of the mast cell: kit(CD117)-ligand as the missing link?","volume":"15","author":"Valent","year":"1994","journal-title":"Immunol. Today"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0590","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1349-7006.1996.tb03112.x","article-title":"Metastatic potential of lymphoma\/leukemia cell lines in SCID mice is closely related to expression of CD44","volume":"87","author":"Kawasaki","year":"1996","journal-title":"Jpn. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0595","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2141.1993.tb03168.x","article-title":"Acute myeloid leukaemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM-1)","volume":"85","author":"Cavenagh","year":"1993","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0600","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0145-2126(01)00036-4","article-title":"A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells","volume":"25","author":"Noguchi","year":"2001","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.semcancer.2019.07.025_bib0605","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1089\/scd.2008.0380","article-title":"Shear stress-mediated adhesion of acute myeloid leukemia and KG-1 cells to endothelial cells involves functional P-selectin","volume":"18","author":"Bistrian","year":"2009","journal-title":"Stem Cells Dev."},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070139","article-title":"E- and P-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model","volume":"8","author":"Wicklein","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.025_bib0615","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/eji.201747086","article-title":"In vivo neutralization of \u03b14 and \u03b27 integrins inhibits eosinophil trafficking and prevents lung injury during tropical pulmonary eosinophilia in mice","volume":"47","author":"Sharma","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"5909","key":"10.1016\/j.semcancer.2019.07.025_bib0620","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0625","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0630","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ccr.2014.04.015","article-title":"Leukemia propagating cells rebuild an evolving niche in response to therapy","volume":"25","author":"Duan","year":"2014","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0635","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","article-title":"Normal and leukemic stem cell niches: insights and therapeutic opportunities","volume":"16","author":"Schepers","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.semcancer.2019.07.025_bib0640","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3324\/haematol.2014.113852","article-title":"A hostel for the hostile: the bone marrow niche in hematologic neoplasms","volume":"100","author":"Krause","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0645","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0650","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.3324\/haematol.2016.159517","article-title":"Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4\/CXCL12 axis","volume":"102","author":"de Rooij","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0655","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","article-title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","volume":"32","author":"Kumar","year":"2018","journal-title":"Leukemia"},{"issue":"9216","key":"10.1016\/j.semcancer.2019.07.025_bib0660","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(00)02241-8","article-title":"Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells","volume":"355","author":"Gunsilius","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.025_bib0665","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2004-07-2514","article-title":"Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics","volume":"105","author":"Fang","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.025_bib0670","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2010-07-297598","article-title":"Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms","volume":"117","author":"Teofili","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0675","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcmd.2016.09.004","article-title":"JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms","volume":"62","author":"Lin","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0680","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000046613","article-title":"Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome","volume":"106","author":"Albitar","year":"2001","journal-title":"Acta Haematol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.025_bib0685","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1182\/blood-2003-05-1634","article-title":"Internal and external autocrine VEGF\/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways","volume":"103","author":"Santos","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.025_bib0690","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1080\/10428190410001712225","article-title":"Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2","volume":"45","author":"Zhang","year":"2004","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0695","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood-2004-05-1846","article-title":"A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease","volume":"105","author":"Fiedler","year":"2005","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.semcancer.2019.07.025_bib0700","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2174\/156802607781696855","article-title":"Molecular design and clinical development of VEGFR kinase inhibitors","volume":"7","author":"Zhong","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0705","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2141.2009.07673.x","article-title":"VEGF\/KDR loop is a target of AG1296 in acute myeloid leukaemia showing FLT3-internal tandem duplications","volume":"145","author":"Torres","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.semcancer.2019.07.025_bib0710","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.exphem.2014.08.003","article-title":"Activation of the vascular niche supports leukemic progression and resistance to chemotherapy","volume":"42","author":"Poulos","year":"2014","journal-title":"Exp. Hematol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0715","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2008.07372.x","article-title":"Antiangiogenesis in haematological malignancies","volume":"143","author":"Li","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.025_bib0720","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2174\/156800911798073078","article-title":"Clinical experience with antiangiogenic therapy in leukemia","volume":"11","author":"Wellbrock","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"issue":"11","key":"10.1016\/j.semcancer.2019.07.025_bib0725","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/leu.2017.245","article-title":"Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site","volume":"31","author":"Hadzijusufovic","year":"2017","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0730","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/10428194.2016.1239258","article-title":"Ponatinib reduces viability, migration, and functionality of human endothelial cells","volume":"58","author":"Gover-Proaktor","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0735","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1182\/blood-2014-09-594432","article-title":"Vascular safety issues in CML patients treated with BCR\/ABL1 kinase inhibitors","volume":"125","author":"Valent","year":"2015","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.semcancer.2019.07.025_bib0740","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1136\/heartjnl-2018-313726","article-title":"Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors","volume":"104","author":"Dobbin","year":"2018","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.025_bib0745","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14740338.2019.1613371","article-title":"An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting TKI-based therapy","volume":"18","author":"Galvano","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0750","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bcp.2010.04.003","article-title":"The bone marrow microenvironment as a sanctuary for minimal residual disease in CML","volume":"80","author":"Nair","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0755","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2010.31.0904","article-title":"Leukemia stem cells and microenvironment: biology and therapeutic targeting","volume":"29","author":"Konopleva","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.025_bib0760","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11899-015-0255-4","article-title":"Targeting the microenvironment in acute myeloid leukemia","volume":"10","author":"Rashidi","year":"2015","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0765","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ajh.24312","article-title":"Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?","volume":"91","author":"Bernasconi","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.025_bib0770","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/2040620715619307","article-title":"Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence","volume":"7","author":"Rashidi","year":"2016","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.semcancer.2019.07.025_bib0775","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood-2018-99-111126","article-title":"BRD4 degradation is a potent approach to block MYC expression and to overcome multiple forms of stem cell resistance in ph+ CML","volume":"132","author":"Peter","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0780","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exphem.2017.09.012","article-title":"Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia","volume":"57","author":"Willmann","year":"2018","journal-title":"Exp. Hematol."},{"issue":"24","key":"10.1016\/j.semcancer.2019.07.025_bib0785","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0790","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1038\/cddis.2012.137","article-title":"CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model","volume":"4","author":"Zhang","year":"2012","journal-title":"Cell Death Dis."},{"issue":"17","key":"10.1016\/j.semcancer.2019.07.025_bib0795","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semcancer.2019.07.025_bib0800","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26414","volume":"64","author":"Cooper","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.025_bib0805","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1038\/bcj.2017.21","article-title":"A phase 1\/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia","volume":"7","author":"Uy","year":"2017","journal-title":"Blood Cancer J."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0810","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00277-018-3229-5","article-title":"CETLAM and PETHEMA groups. A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia","volume":"97","author":"Mart\u00ednez-Cuadr\u00f3n","year":"2018","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.025_bib0815","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/leu.2011.360","article-title":"Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib","volume":"26","author":"Weisberg","year":"2012","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.semcancer.2019.07.025_bib0820","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood-2011-05-355396","article-title":"Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML","volume":"120","author":"Agarwal","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0825","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2008.364","article-title":"The stem cell factor-c-KIT pathway must be inhibited to enable apoptosis induced by BCR-ABL inhibitors in chronic myelogenous leukemia cells","volume":"23","author":"Belloc","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2019.07.025_bib0830","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1182\/blood.V122.21.3944.3944","article-title":"VLA4 blockade in acute myeloid leukemia","volume":"122","author":"Hsieah","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.025_bib0835","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm909","article-title":"Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia","volume":"9","author":"Matsunaga","year":"2003","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.025_bib0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093173","article-title":"SDA, a DNA aptamer inhibiting E- and P-selectin mediated adhesion of cancer and leukemia cells, the first and pivotal step in transendothelial migration during metastasis formation","volume":"9","author":"Faryammanesh","year":"2014","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.semcancer.2019.07.025_bib0845","doi-asserted-by":"crossref","first-page":"32532","DOI":"10.18632\/oncotarget.8687","article-title":"Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia","volume":"7","author":"Vey","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.025_bib0850","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2013-11-538694","article-title":"Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche","volume":"123","author":"Krause","year":"2014","journal-title":"Blood"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19302147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19302147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T17:04:04Z","timestamp":1715879044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19302147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":170,"alternative-id":["S1044579X19302147"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.025","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redistribution, homing and organ-invasion of neoplastic stem cells in myeloid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}